selected publications
- Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons. Journal of imaging. 2025 Review GET IT
-     
    
    
                     Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial. 
 
                    The Lancet. Oncology. 
            
             2024
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 3
- First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. 2024 GET IT
